Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 529 across all filing types
Latest filing 2022-02-14 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of the outcome of a board meeting held on February 14, 2022, where the Board of Directors approved the unaudited financial results for the quarter and nine months ended December 31, 2021. It includes an Independent Auditor's Review Report on the interim standalone financial results, which is a limited review rather than a full audit. The document contains actual financial data and analysis for the interim period, including income, expenses, profit before tax, tax expense, and profit after tax, as well as other comprehensive income. The presence of unaudited financial results for a period shorter than a full fiscal year and the auditor's limited review report aligns with the characteristics of an Interim / Quarterly Report. The document is not merely an announcement of a report but contains substantive financial data and analysis. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2022-02-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 70% confidence The document is an intimation letter about an upcoming earnings conference call for Q3 & 9M FY22 results. It mentions the date and time of the call, dial-in details, and that the call will include a management discussion and Q&A session. There is no actual financial data or detailed financial report included in the document. The document is essentially an announcement of the earnings call event, not the transcript or the earnings release itself. Therefore, it fits best under the category of Call Transcript (CT) as it relates to the earnings conference call, but since it is only an announcement of the call and not the transcript, it is more appropriate to classify it as Regulatory Filings (RNS) because it does not contain the transcript or the earnings release itself. However, given the options, the best fit is Call Transcript (CT) with moderate confidence because it is about the earnings call event.
2022-02-12 English
Board Meeting — Financial Results
Regulatory Filings Classification · 90% confidence The document text is extremely short (589 characters) and contains only address and contact information related to stock exchanges and listing compliance. There is no substantive financial data, report content, or detailed information. It appears to be a brief communication or notice rather than a full report or detailed announcement. Given the lack of any report or announcement content, and the presence of stock exchange and compliance references, this document best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2022-02-08 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is an official communication dated February 4, 2022, addressed to stock exchanges (BSE and NSE) regarding the allotment of equity shares under the Rossari Employee Stock Option Plan – 2019. It references regulatory approvals and compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, and SEBI (Share Based Employee Benefits) Regulations, 2014. The content details the allotment of shares, share capital increase, and includes an annexure with specific disclosures about the share issuance. The document is an announcement of a share allotment event under an employee stock option plan, which is a capital change event. It is not a full financial report, audit, or earnings release, nor is it a proxy or voting result. The document is not a report publication announcement but a direct notification of a capital change. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length is 4755 characters, sufficient to contain substantive information about the share allotment event.
2022-02-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (866 characters) and mostly consists of fragmented address and contact information, stock codes, and references to stock exchanges. There is no substantive financial data, no discussion of financial results, no management commentary, no voting results, no legal proceedings, no audit information, or any other detailed report content. The text appears to be a brief notice or announcement, possibly related to listing or regulatory compliance, but without enough detail to classify as a full report or detailed filing. Given the lack of detailed content and the presence of stock codes and exchange references, the document best fits the category of a Regulatory Filing (RNS), which is a fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-01-28 English
Board Meeting — Board meeting Rescheduled
Regulatory Filings Classification · 95% confidence The document text is extremely short (753 characters) and contains no substantive content or financial data. It mainly consists of addresses and stock codes for stock exchanges, with no indication of financial results, management changes, or other report content. There are no references to any report, filing, or announcement beyond listing compliance information. Given the brevity and lack of report content, this document is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other specific categories.
2022-01-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.